Transcode Therapeutics

About:

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

Website: https://www.transcodetherapeutics.com

Twitter/X: RNAoncology

Top Investors: National Cancer Institute, National Institutes of Health, Red Cedar Ventures, TRITON FUNDS LLC

Description:

TransCode Therapeutics is an emerging RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, which they believe has blockbuster potential, targets an RNA molecule that is the driver of metastatic disease across multiple tumor types and has been validated pre-clinically in its lab at MGH.